Deborah A Elder1, Lindsey N Hornung2, Patricia M Herbers2, Ron Prigeon3, Jessica G Woo2, David A D'Alessio4. 1. Division of Endocrinology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH. Electronic address: Deborah.elder@cchmc.org. 2. Division of Biostatistics and Epidemiology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH. 3. Department of Medicine, University of Maryland School of Medicine, Baltimore, MD; Department of Medicine, Baltimore Veterans Affairs Medical Center Geriatric Research, Education and Clinical Center, Baltimore, MD. 4. Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, OH; Department of Medicine, Cincinnati VA Medical Center, Cincinnati, OH.
Abstract
OBJECTIVE: To identify pathophysiologic changes that lead to the onset of type 2 diabetes (T2DM) in adolescents. STUDY DESIGN: Obese adolescents with normal glucose tolerance (n = 41) were studied longitudinally over the course of 4 years with serial measure of the acute insulin response to glucose (AIRg) as well as proinsulin (PI) concentrations. Insulin resistance was estimated with the homeostatic model assessment of insulin resistance (HOMA-IR), the disposition index (DI) computed as AIRg × 1/HOMA-IR, and intravenous glucose tolerance estimated as the glucose disappearance constant. RESULTS: Four adolescents developed diabetes mellitus (DM) during the study, and the rest of the cohort remained nondiabetic. Baseline PI exceeded the IQR of the nondiabetic group in 3 of 4 subjects with DM, and all had >85% reduction from baseline AIRg, and DI, within 6 months of diagnosis. All the subjects with DM gained weight over the course of the study, but these changes paralleled those for the nondiabetic group. HOMA-IR increased substantially in 1 of the subjects with DM at the time of diagnosis but was comparable with baseline in the other 3. The DI and glucose disappearance constant of the subjects with DM was less than the 10th percentile of the nondiabetic group before and after diagnosis. CONCLUSION: Conversion from normal glucose tolerance to T2DM in adolescents can occur rapidly, and the onset of T2DM is heralded by a substantial decrease in AIRg and DI, as well as increased release of PI. These results support loss of β-cell function as the proximate step in the development of T2DM in this age group.
OBJECTIVE: To identify pathophysiologic changes that lead to the onset of type 2 diabetes (T2DM) in adolescents. STUDY DESIGN:Obese adolescents with normal glucose tolerance (n = 41) were studied longitudinally over the course of 4 years with serial measure of the acute insulin response to glucose (AIRg) as well as proinsulin (PI) concentrations. Insulin resistance was estimated with the homeostatic model assessment of insulin resistance (HOMA-IR), the disposition index (DI) computed as AIRg × 1/HOMA-IR, and intravenous glucose tolerance estimated as the glucose disappearance constant. RESULTS: Four adolescents developed diabetes mellitus (DM) during the study, and the rest of the cohort remained nondiabetic. Baseline PI exceeded the IQR of the nondiabetic group in 3 of 4 subjects with DM, and all had >85% reduction from baseline AIRg, and DI, within 6 months of diagnosis. All the subjects with DM gained weight over the course of the study, but these changes paralleled those for the nondiabetic group. HOMA-IR increased substantially in 1 of the subjects with DM at the time of diagnosis but was comparable with baseline in the other 3. The DI and glucose disappearance constant of the subjects with DM was less than the 10th percentile of the nondiabetic group before and after diagnosis. CONCLUSION: Conversion from normal glucose tolerance to T2DM in adolescents can occur rapidly, and the onset of T2DM is heralded by a substantial decrease in AIRg and DI, as well as increased release of PI. These results support loss of β-cell function as the proximate step in the development of T2DM in this age group.
Authors: Valeriya Lyssenko; Peter Almgren; Dragi Anevski; Roland Perfekt; Kaj Lahti; Michael Nissén; Bo Isomaa; Björn Forsen; Nils Homström; Carola Saloranta; Marja-Riitta Taskinen; Leif Groop; Tiinamaija Tuomi Journal: Diabetes Date: 2005-01 Impact factor: 9.461
Authors: Lawrence M Dolan; Judy Bean; David D'Alessio; Robert M Cohen; John A Morrison; Elizabeth Goodman; Stephen R Daniels Journal: J Pediatr Date: 2005-06 Impact factor: 4.406
Authors: Deborah A Elder; Ronald L Prigeon; R Paul Wadwa; Lawrence M Dolan; David A D'Alessio Journal: J Clin Endocrinol Metab Date: 2005-11-01 Impact factor: 5.958
Authors: Johan Staaf; Viktor Labmayr; Katharina Paulmichl; Hannes Manell; Jing Cen; Iris Ciba; Marie Dahlbom; Kirsten Roomp; Christian-Heinz Anderwald; Matthias Meissnitzer; Reinhard Schneider; Anders Forslund; Kurt Widhalm; Jonas Bergquist; Håkan Ahlström; Peter Bergsten; Daniel Weghuber; Joel Kullberg Journal: Pancreas Date: 2017-03 Impact factor: 3.327
Authors: Lyudmila V Gromova; Alexandr S Polozov; Elizaveta V Savochkina; Anna S Alekseeva; Yulia V Dmitrieva; Oleg V Kornyushin; Andrey A Gruzdkov Journal: Nutrients Date: 2022-01-17 Impact factor: 5.717